Gomez-Pinilla and Hillman (2013) synthesize ~198 references across human neuroimaging, EEG/ERP, and rodent molecular biology, arguing that aerobic fitness spares age-related gray/white matter loss in frontal, temporal, and parietal regions, that fitter individuals allocate more attentional resources (larger P3 amplitude) and process stimuli faster (shorter P3 latency), and that BDNF sits at the interface of energy metabolism and synaptic plasticity . A subsequent rat study directly validates the mechanistic core: 8 weeks of treadmill running raised hippocampal BDNF (250Β±30 to 400Β±45 pg/mg), IGF-1 (150Β±20 to 220Β±25 pg/mg), dentate gyrus BrdU+ cells (120Β±10 to 180Β±15 cells/mmΒ²), and hippocampal volume (25.0Β±1.2 to 27.5Β±1.5 mmΒ³), with improved Morris water maze performance .
Later human work broadly confirms the review's lifespan claims but with smaller, more selective effects than the ~0.5 SD headline: a meta-analysis of 31 studies (4,593 children aged 6-12) found acute exercise modestly improves attention (g=0.24, 95% CI 0.08β0.40) and longitudinal programs g=0.37 overall, with cognitively engaging activity outperforming pure aerobic exercise (g=0.53 vs 0.29), and high heterogeneity (IΒ² up to 91%) plus low mean study quality (PEDro ~4.3/10) temper causal confidence . In clinical populations, 12 weeks of physical activity improved working memory and motor performance in 43 children with ADHD , and a 3-month trial in 50 obese adolescents improved set-shifting (WCST total errors F(1,48)=24.52, p<.001, partial Ξ·Β²=.34) alongside heart rate variability gains .
Reported: consistent cross-species convergence on BDNF/IGF-1 as mediators. Author interpretations with weaker grounding: the epigenetic BDNF promoter IV story and the "exercise as therapy for depression/dementia" extrapolations rest largely on rodent work and epidemiology; the review itself acknowledges publication-bias risk toward positive exercise findings . Key limitations: most cited human neuroimaging is cross-sectional (healthy-user bias β fitter people differ in SES, diet, baseline cognition); the 2% hippocampal volume gain RCT (Erickson 2011, n=120) is cited as "definitive" but is a single trial; rodent blocking experiments (TrkB-IgG) establish necessity in animals, not dose-response in humans; no systematic null-result search; the diet-exercise DHA synergy relies on the authors' own lab studies. What would falsify: large adequately powered RCTs showing no cognitive benefit (partially challenged for children by the g=0.24 CI lower bound near zero), failure to replicate BDNF mediation in humans, or demonstration that fitness-cognition links vanish after controlling for confounders. The mechanistic framework remains scientifically generative 13 years on, but effect-size inflation versus later meta-analyses suggests cautious translation.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.